文献速递慢阻肺

重度肺气肿支气管内活瓣治疗后靶肺叶体积缩减的最小重要差值

Minimal important difference of target lobar volume reduction after endobronchial valve treatment for emphysema.
PubMed 文献 · Respirology · 2017-09-15

该研究基于两项支气管镜肺减容试验的318例重度肺气肿患者,采用锚定法确定6个月随访时靶肺叶体积缩减(TLVR)的最小重要差值(MID)。以FEV1、RV和SGRQ为锚定指标计算的MID分别为-587 mL、-534 mL和-560 mL,合并MID为-563 mL。

要点

  • EBV治疗后6个月TLVR的合并MID为-563 mL。
  • 以FEV1、RV、SGRQ为锚定的MID分别为-587 mL、-534 mL、-560 mL。
  • 该值可用于解读试验结果、指导临床及设计未来肺减容研究。

核心结论

  • 采用锚定法确定重度肺气肿患者EBV治疗后6个月随访时TLVR的MID为-563 mL。

研究设计与样本

  • 分析两项BLVR试验中318例重度肺气肿患者,采用锚定法在6个月随访时确定TLVR的MID。
  • 以FEV1、RV和SGRQ作为锚定指标。

主要发现

  • 以FEV1为锚定的TLVR MID为-587 mL。
  • 以RV为锚定的TLVR MID为-534 mL。
  • 以SGRQ为锚定的TLVR MID为-560 mL。
  • 三个锚定MID的平均值即合并MID为-563 mL。

关键数值与推荐

  • TLVR常用截断值为-350 mL,用于表达可感知的临床获益。
  • 本研究确定的TLVR MID为-563 mL(6个月随访,重度肺气肿EBV治疗后)。

临床怎么用

  • 该MID可用于解读肺减容试验结果和临床实践,以及设计未来肺减容研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVE: Target lobar volume reduction (TLVR) is an important efficacy outcome measure for bronchoscopic lung volume reduction (BLVR) treatment using one-way endobronchial valves (EBV) in patients with severe emphysema. The commonly used cut-off value for TLVR that expresses a perceivable clinical benefit is -350 mL. However, a scientifically determined minimal important difference (MID) for TLVR never has been published. The objective of the present study was to determine the MID for TLVR on HRCT in patients who were treated with EBV. METHODS: A total of 318 patients with severe emphysema from two BLVR trials were analysed. Anchor-based methods were used to define the TLVR MID at 6 months follow-up. Forced expiratory volume in 1 s (FEV1 ), residual volume (RV) and St. George's Respiratory Questionnaire (SGRQ) were used as anchors. RESULTS: The calculated TLVR MID with each anchor was: FEV1 -587 mL, RV -534 mL and SGRQ -560 mL. The combined MID (average of the three anchor-based MIDs) was -563 mL. CONCLUSION: Using the anchor-based method, we established a TLVR MID of -563 mL in patients with severe emphysema at 6 months follow-up after EBV treatment. This value can be useful for both interpreting the results from trials and clinical practice, as well as for designing future studies on lung volume reduction.

来源:Respirology,查看原文。版权归原作者所有。

引用

  1. Welling JBA, Hartman JE, van Rikxoort EM, et al. Minimal important difference of target lobar volume reduction after endobronchial valve treatment for emphysema. Respirology. 2017. PMID: 28913877. doi:10.1111/resp.13178

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。